S. Schmidt

发表

Adaptive control in an artificial pancreas for people with type 1 diabetes

Niels Kjølstad Poulsen, Henrik Madsen, Dimitri Boiroux, 2017 .

Preference for Subcutaneously Administered Low-Dose Glucagon Versus Orally Administered Glucose for Treatment of Mild Hypoglycemia: A Prospective Survey Study

K. Nørgaard, S. Schmidt, R. Tetzschner, 2019, Diabetes Therapy.

Use of an Automated Bolus Calculator in MDI-Treated Type 1 Diabetes

K. Nørgaard, S. Schmidt, M. Meldgaard, 2012, Diabetes Care.

Exercise effects in a virtual type 1 diabetes patient: Using stochastic differential equations for model extension

J. B. Jørgensen, H. Madsen, K. Nørgaard, 2013 .

Predicting Plasma Glucose From Interstitial Glucose Observations Using Bayesian Methods

J. B. Jørgensen, H. Madsen, K. Nørgaard, 2014, Journal of diabetes science and technology.

Feasibility of a New Approach to Initiate Insulin in Type 2 Diabetes

N. K. Poulsen, K. Nørgaard, Dimitri Boiroux, 2020, Journal of diabetes science and technology.

Continuous glucose monitoring‐enabled insulin‐pump therapy in diabetic pregnancy

K. Nørgaard, A. Secher, S. Schmidt, 2010, Acta obstetricia et gynecologica Scandinavica.

Glucose Sensor Accuracy After Subcutaneous Glucagon Injections Near to Sensor Site.

K. Nørgaard, S. Schmidt, R. Tetzschner, 2020, Diabetes technology & therapeutics.

Comparison of Continuous Glucose Monitoring Accuracy Between Abdominal and Upper Arm Insertion Sites.

J. B. Jørgensen, K. Nørgaard, S. Schmidt, 2019, Diabetes technology & therapeutics.

Glucagon for hypoglycaemia treatment in type 1 diabetes

K. Nørgaard, S. Schmidt, A. Ranjan, 2020, Diabetes/metabolism research and reviews.

Evaluation of pharmacokinetic model designs for subcutaneous infusion of insulin aspart

Erin J. Mansell, J. B. Jørgensen, H. Madsen, 2017, Journal of Pharmacokinetics and Pharmacodynamics.

Low-Carbohydrate Diet Impairs the Effect of Glucagon in the Treatment of Insulin-Induced Mild Hypoglycemia: A Randomized Crossover Study

J. Holst, K. Nørgaard, S. Schmidt, 2016, Diabetes Care.

Effect of adjunctive glucose-lowering drugs on body weight in people with type 1 diabetes: a systematic review and network meta-analysis protocol

Lauge Neimann Rasmussen, K. Nørgaard, S. Schmidt, 2020, BMJ Open.

Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes

Henrik Madsen, John Bagterp Jørgensen, Jan Kloppenborg Møller, 2017, Journal of diabetes science and technology.

Validation of a Simulation Model Describing the Glucose-Insulin-Glucagon Pharmacodynamics in Patients with Type 1 Diabetes

J. B. Jørgensen, J. Holst, H. Madsen, 2017 .

The effect of preceding glucose decline rate on low‐dose glucagon efficacy in individuals with type 1 diabetes: A randomized crossover trial

J. Holst, K. Nørgaard, S. Schmidt, 2020, Diabetes, obesity & metabolism.

Hospital Diabetes Meeting 2022

D. Klonoff, S. Schmidt, G. Umpierrez, 2022, Journal of diabetes science and technology.

Glucose sensor excludes hypoglycaemia as cause of death.

K. Nørgaard, S. Schmidt, 2012, Diabetes research and clinical practice.

Exploring factors influencing HbA1c and psychosocial outcomes in people with type 1 diabetes after training in advanced carbohydrate counting.

K. Nørgaard, S. Schmidt, T. Almdal, 2017, Diabetes research and clinical practice.

Machine Learning Glycemic Predictions for the Hospital Using Electronic Health Record Data

D. Klonoff, S. Schmidt, G. Umpierrez, 2022 .

Values and control in type 1 diabetes beyond glycemic outcomes: A qualitative interview study of everyday life with an insulin pump

B. Cleal, K. Nørgaard, S. Schmidt, 2021, Chronic illness.

The endocrine pancreas during exercise in people with and without type 1 diabetes: Beyond the beta-cell

M. B. Christensen, K. Nørgaard, S. Schmidt, 2022, Frontiers in Endocrinology.

Is reimbursement for alerts and real-time continuous glucose monitoring needed?

K. Nørgaard, S. Schmidt, 2021, The Lancet.

Glucose response to low-dose glucagon for insulin-induced mild hypoglycaemia after 12 weeks of high versus low carbohydrate diet. A pilot study

J. Holst, M. B. Christensen, K. Nørgaard, 2020, medRxiv.

Diabetic Ketoacidosis in A Person with Insulin Pump-Treated Type 1 Diabetes Mellitus while Following A Very Low Carbohydrate Diet – A Case Report

K. Nørgaard, S. Schmidt, A. Ranjan, 2019, Archives of Clinical and Medical Case Reports.

Psychosocial Factors and Adherence to Continuous Glucose Monitoring in Type 1 Diabetes

K. Nørgaard, A. Duun-Henriksen, S. Schmidt, 2012, Journal of Diabetes Science and Technology.

Bolus Calculators

Kirsten Nørgaard, Signe Schmidt, K. Nørgaard, 2014, Journal of diabetes science and technology.

Effects of initiating insulin pump therapy in the real world: a nationwide, register-based study of adults with type 1 diabetes.

K. Nørgaard, S. Schmidt, K. Olsen, 2022, Diabetes research and clinical practice.

Insulin Pump Treatment in Adults with Type 1 Diabetes in the Capital Region of Denmark: Design and Cohort Characteristics of the Steno Tech Survey

B. Cleal, K. Nørgaard, S. Schmidt, 2021, Diabetes Therapy.

An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.

Henrik Madsen, Dimitri Boiroux, John Bagterp Jørgensen, 2015, Therapeutic delivery.

Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump‐treated type 1 diabetes

K. Nørgaard, S. Schmidt, T. Halldorsson, 2021, Diabetes, obesity & metabolism.

Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin‐pump‐treated patients with type 1 diabetes: The Lira Pump trial—a randomized, double‐blinded, placebo‐controlled trial

K. Nørgaard, S. Schmidt, S. Madsbad, 2019, Diabetes, obesity & metabolism.

Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post‐hoc analysis of a randomized crossover trial

T. Suvitaival, F. Pociot, M. B. Christensen, 2021, Endocrinology, diabetes & metabolism.

Effect of adjunctive glucose-lowering drugs on body weight in people with type 1 diabetes: a systematic review and network meta-analysis protocol

Lauge Neimann Rasmussen, K. Nørgaard, S. Schmidt, 2020, BMJ Open.

Model Identification Using Stochastic Differential Equation Grey-Box Models in Diabetes

Henrik Madsen, John Bagterp Jørgensen, Anne Katrine Duun-Henriksen, 2013, Journal of diabetes science and technology.

Effects of everyday life events on glucose, insulin, and glucagon dynamics in continuous subcutaneous insulin infusion-treated type 1 diabetes: collection of clinical data for glucose modeling.

Henrik Madsen, Henrik Bengtsson, John Bagterp Jørgensen, 2012, Diabetes technology & therapeutics.

Overnight glucose control in people with type 1 diabetes

Niels Kjølstad Poulsen, Henrik Madsen, Dimitri Boiroux, 2018, Biomed. Signal Process. Control..

Effects of subcutaneous, low‐dose glucagon on insulin‐induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes

J. Holst, K. Nørgaard, S. Schmidt, 2016, Diabetes, obesity & metabolism.

Dual‐hormone treatment with insulin and glucagon in patients with type 1 diabetes

J. Holst, K. Nørgaard, S. Schmidt, 2015, Diabetes/metabolism research and reviews.

Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study

J. Holst, K. Nørgaard, S. Schmidt, 2019, Diabetologia.

Glycaemia around exercise in adults with type 1 diabetes using automated and non-automated insulin delivery pumps: A switch pilot trial.

M. B. Christensen, S. Schmidt, R. Bracken, 2023, Diabetes technology & therapeutics.

Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals.

S. Schmidt, M. Riddell, T. Skinner, 2021, The lancet. Diabetes & endocrinology.

Education programmes for persons with type 1 diabetes using an insulin pump: A systematic review

Lauge Neimann Rasmussen, K. Nørgaard, S. Schmidt, 2020, Diabetes/metabolism research and reviews.

Development of a glucagon sensitivity test in humans: Pilot data and the GLUSENTIC study protocol

J. Holst, J. Rungby, K. Nørgaard, 2022, Peptides.

Model-Based Closed-Loop Glucose Control in Type 1 Diabetes: The DiaCon Experience

Niels Kjølstad Poulsen, Henrik Madsen, Dimitri Boiroux, 2013, Journal of diabetes science and technology.

Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes

K. Nørgaard, S. Schmidt, A. Ranjan, 2017, Journal of diabetes science and technology.

Associations between insulin pump self‐management and HbA1c in type 1 diabetes

S. Schmidt, H. Andersen, U. Pedersen-Bjergaard, 2023, Diabetic Medicine.

Glucagon Administration Strategies for a Dual-Hormone Artificial Pancreas

Niels Kjølstad Poulsen, Henrik Madsen, Morten Hagdrup, 2015 .

Tuning of Controller for Type 1 Diabetes Treatment with Stochastic Differential Equations

Niels Kjølstad Poulsen, Henrik Madsen, Peter Ruhdal Jensen, 2012 .

Bi-hormonal Closed-loop Control of Blood Glucose for People With Type 1 Diabetes - the Diacon Project

J. B. Jørgensen, H. Madsen, N. K. Poulsen, 2015 .

Sensor-augmented pump therapy at 36 months.

K. Nørgaard, S. Schmidt, 2012, Diabetes technology & therapeutics.

Relationship between Optimum Mini‐doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes – A Simulation Study

J. B. Jørgensen, J. Holst, H. Madsen, 2018, Basic & clinical pharmacology & toxicology.

Use of advanced carbohydrate counting and an automated bolus calculator in clinical practice: the BolusCal® training concept

K. Nørgaard, S. Schmidt, M. Meldgaard, 2015 .

Effects of Preceding Ethanol Intake on Glucose Response to Low-Dose Glucagon in Individuals With Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study

J. Holst, K. Nørgaard, S. Schmidt, 2018, Diabetes Care.

Short‐term effects of a low carbohydrate diet on glycaemic variables and cardiovascular risk markers in patients with type 1 diabetes: A randomized open‐label crossover trial

J. Holst, K. Nørgaard, S. Schmidt, 2017, Diabetes, obesity & metabolism.

Low versus high carbohydrate diet in type 1 diabetes: A 12‐week randomized open‐label crossover study

M. B. Christensen, K. Nørgaard, S. Schmidt, 2019, Diabetes, obesity & metabolism.

Associations between clinical and psychosocial factors and HbA1c in adult insulin pump users with type 1 diabetes

B. Cleal, S. Schmidt, I. Willaing, 2023, Acta Diabetologica.

Continuous glucose monitoring‐enabled insulin‐pump therapy in diabetic pregnancy

K. Nørgaard, A. Secher, S. Schmidt, 2010, Acta obstetricia et gynecologica Scandinavica.

Long-Term Adherence to Automated Bolus Calculators

K. Nørgaard, S. Schmidt, K. Neergaard, 2017, Journal of Diabetes Science and Technology.

Exploring factors influencing HbA1c and psychosocial outcomes in people with type 1 diabetes after training in advanced carbohydrate counting.

K. Nørgaard, S. Schmidt, T. Almdal, 2017, Diabetes research and clinical practice.

Effects of advanced carbohydrate counting guided by an automated bolus calculator in Type 1 diabetes mellitus (StenoABC): a 12‐month, randomized clinical trial

K. Nørgaard, K. Nørgaard, S. Schmidt, 2017, Diabetic medicine : a journal of the British Diabetic Association.

Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms.

S. Schmidt, J. Nybing, S. Haugaard, 2024, Metabolism: clinical and experimental.

Low-Dose Dasiglucagon Versus Oral Glucose for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes: A Phase 2, Randomized, Three-Arm Crossover Study.

K. Nørgaard, S. Schmidt, A. Ranjan, 2022, Diabetes care.